dm+d

359380005

Medicine Compliance Aid Stability

Regurin XLMylan

Mylan
Regurin XL
Capsules m/r 60mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special precautions for storage
23 November 2022

RegurinMylan

Mylan
Regurin
Tablets f/c 20mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight container. Protect from light
23 November 2022

Lactation Safety Information

Oxybutynin
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties although long half-life increases risk of accumulation in breastfed infants
Monitor infant for anticholinergic effects, e.g. urinary retention, colic and constipation
10 August 2020